Human and Translational Immunology

描述（由申请人提供）：我们提出了一个新的培训计划，在人类和转化免疫学在耶鲁大学医学院。在过去的30年里，免疫生物学有了惊人的发展，改变了临床医学。在很大程度上，这种增长是由于实验模型的可用性，特别是近交系小鼠，其中实验方法已经得到很好的发展，可以利用遗传修饰来解决假设。然而，仅在啮齿动物模型中的研究不足以理解人类免疫生物学以及疾病和治疗中发生的人类免疫应答的干扰或操纵。小鼠和人类免疫反应之间存在许多差异，理解这些差异非常重要，以便新的科学发展可以应用于患者的治疗。重要的是，缺乏同时具有科学和临床背景的研究人员，使他们能够弥合基础免疫学发现与临床医学应用之间的差距。该计划旨在提供培训，以培养能够填补这一空白的领导者。它不同于免疫生物学和临床专业的传统培训计划，强调将基本免疫学发现应用于临床环境。该学院包括杰出的翻译科学家，他们在患者和/或人类疾病的小鼠模型中研究疾病相关机制，而人类组织不可用。学员将包括来自临床或研究生培训计划的博士后候选人，他们希望在人类转化免疫生物学方面进行强化培训，以便在研究医学领域发展职业生涯。该计划是通过免疫生物学系管理，但教师是几个部门的成员-临床和基础科学，在医学院。培训课程包括教学指导和人体细胞和组织研究经验，临床研究方法以及负责任的研究行为。研究经验包括7个主题领域中的一个或多个领域的培训，涵盖了从遗传学，细胞免疫学到纳米粒子使用的广泛的人类疾病和技术。 相关性（参见说明）：基础免疫学的突破有可能为许多人类疾病带来新的治疗方法。临床科学家缺乏能够将这些发展转化为患者的能力。这个项目将培养这样的人才。致力于转化研究的博士后研究员将接受人类疾病和治疗免疫学的密集培训。

DESCRIPTION (provided by applicant): We propose a new training program in Human and Translational Immunology at the Yale School of Medicine. There has been extraordinary growth in immunobiology the past 3 decades that has transformed clinical medicine. To a large extent, this growth is the result of the availability of experimental models, particularly inbred strains of mice, in which experimental methods have been well developed and genetic modifications can be exploited to address hypotheses. However, the studies in rodent models alone are not sufficient for understanding human immunobiology and the disturbances or manipulations of human immune responses that occur with disease and treatments. There are many differences between murine and human immune responses that are important to understand so that new scientific developments can be applied to the treatment of patients. Importantly, there is a shortage of investigators that have both the scientific and clinical backgrounds to enable them to bridge the gap between basic immunologic discoveries and the application to clinical medicine. This program is designed to provide training to develop leaders who can fill that void. It differs from traditional training programs in Immunobiology and clinical specialties in its emphasis on the application of basic immunologic discoveries to the clinical setting. The faculty include outstanding translational scientists who study disease relevant mechanisms in patients and/or in murine models of human disease when human tissues are not available. The trainees will include post-doctoral candidates from clinical or graduate training programs who desire intensive training in Human Translational Immunobiology in order to develop a career in investigative medicine. The program is administered through the Department of Immunobiology but the faculty are members of several departments - clinical and basic science, in the Medical School. The training curriculum involves didactic instruction and experience in studies with human cells and tissues, clinical research methods, and the responsible conduct of research. The research experience includes training in one or more of 7 thematic areas that cover a broad spectrum of human diseases and technologies from genetics, cellular immunology, to the use of nanoparticles. RELEVANCE (See instructions): There have been breakthroughs in basic immunology that have the potential to lead to new therapies for many human conditions. There is a shortfall of clinical scientists able to translate these developments to patients. This proposed program will train such individuals. Postdoctoral fellows, with a commitment to translational research will receive intense training in immunology of human disease and therapies.